These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18275902)

  • 1. The effect of statin use at the time of autologous transplant on response and survival in multiple myeloma.
    Hamadani M; Hade E; Benson DM; Hofmeister CC
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):351-2. PubMed ID: 18275902
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis.
    Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
    Am J Hematol; 2008 Aug; 83(8):614-7. PubMed ID: 18429054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandem bone marrow transplantation in multiple myeloma.
    Chng WJ
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15074003
    [No Abstract]   [Full Text] [Related]  

  • 5. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation in multiple myeloma.
    Bladé J
    Haematologica; 2006 Sep; 91(9):1157. PubMed ID: 16956811
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myeloma.
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Leung N; Gastineau DA
    Bone Marrow Transplant; 2007 May; 39(10):605-11. PubMed ID: 17369867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE.
    Srikanth M; Davies FE; Wu P; Jenner MW; Ethell ME; Potter MN; Shaw BE; Saso RM; Dines S; Morgan GJ
    Eur J Haematol; 2008 Dec; 81(6):432-6. PubMed ID: 18691254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
    Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
    Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of early relapse after auto-SCT for multiple myeloma.
    Kumar S; Mahmood ST; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Dingli D; Rajkumar SV; Litzow MR; Gertz MA
    Bone Marrow Transplant; 2008 Sep; 42(6):413-20. PubMed ID: 18587435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tandem bone marrow transplantation in multiple myeloma.
    Murashige N; Kishi Y
    N Engl J Med; 2004 Apr; 350(14):1466-7; author reply 1466-7. PubMed ID: 15070801
    [No Abstract]   [Full Text] [Related]  

  • 12. Allografting or autografting for myeloma.
    Moreau P; Harousseau JL; Attal M
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600892
    [No Abstract]   [Full Text] [Related]  

  • 13. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
    Cheema PK; Zadeh S; Kukreti V; Reece D; Chen C; Trudel S; Mikhael J
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):686-93. PubMed ID: 19450753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
    Kumar SK; Dingli D; Dispenzieri A; Lacy MQ; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA
    Bone Marrow Transplant; 2008 Jun; 41(12):1013-9. PubMed ID: 18332915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.
    Mehta J
    J Natl Cancer Inst; 2009 Oct; 101(20):1430-1; author reply 1431-3. PubMed ID: 19794130
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of autologous peripheral blood stem cell transplantation for multiple myeloma: a multi-institutional survey].
    Inaba W; Shimazaki C
    Rinsho Ketsueki; 2002 May; 43(5):337-40. PubMed ID: 12096481
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of second autografts in the management of myeloma at first relapse.
    Alvares CL; Davies FE; Horton C; Patel G; Powles R; Morgan GJ
    Haematologica; 2006 Jan; 91(1):141-2. PubMed ID: 16434386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
    Harousseau JL; Avet-Loiseau H; Attal M; Charbonnel C; Garban F; Hulin C; Michallet M; Facon T; Garderet L; Marit G; Ketterer N; Lamy T; Voillat L; Guilhot F; Doyen C; Mathiot C; Moreau P
    J Clin Oncol; 2009 Dec; 27(34):5720-6. PubMed ID: 19826130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma.
    Percy LA; Moore SE; Qian W; Dorman J; Rabin N; Watts M; Linch DC; Yong KL
    Br J Haematol; 2012 May; 157(4):494-6. PubMed ID: 22512342
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal timing for transplant in multiple myeloma.
    Rajkumar SV
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):684-6. PubMed ID: 22402513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.